Showing results (101-110 of 155) with videos related to
Sort By:
Pageof 16
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Changes of blood viscosity in patients treated with 5-fluorouracil--a link to cardiotoxicity?M Cwikiel, S U Persson, H Larsson, et al.BMC Geriatrics|September 22, 2023
Health-related quality of life in stroke survivors: a 5-year follow-up of The Fall Study of Gothenburg (FallsGOT)Mårten Segerdahl, Per-Olof Hansson, Carina M Samuelsson, et al.Scandinavian Journal of Immunology|January 1, 1978
Different requirements for T cells responding to various doses of concanavalin AU Persson, P H Bick, L Hammarströme, et al.Journal of Immunological Methods|August 9, 1988
Enumeration of IFN-gamma-producing cells by flow cytometry. Comparison with fluorescence microscopyU Andersson, G Halldén, U Persson, et al.Cellular Immunology|July 1, 1992
Assembly of MHC class I molecules in ex vivo carcinoma cells induced by IFN-gamma or by a binding peptideP Wang, F Vánky, Z Végh, et al.Journal of Immunological Methods|January 17, 1989
Improved cell depletion in a panning technique using covalent binding of immunoglobulins to surface modified polystyrene dishesP H Larsson, J Hed, S G Johansson, et al.Health and Quality of Life Outcomes|July 30, 2015
Health related quality of life in patients with actinic keratosis--an observational study of patients treated in dermatology specialist care in DenmarkGunnel Ragnarson Tennvall, J M Norlin, I Malmberg, et al.Scandinavian Journal of Immunology|February 1, 1989
Recombinant protein A of non-staphylococcal origin is not mitogenic for human peripheral lymphocytes. Mitogenicity of natural protein A is caused by a contaminantU Persson, M Inganäs, C I Smith, et al.Acta Orthopaedica Scandinavica|October 1, 1991
Cost effectiveness of blood substitution in elective orthopedic operationsA Elawad, G Benoni, F Montgomery, et al.Bone Marrow Transplantation|January 1, 1992
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblingsO Ringdén, S Klaesson, B Sundberg, et al.Pageof 16